Publications

5674 Results

Quality of pathologic response and surgery correlate with survival for completely resected bladder cancer following neoadjuvant chemotherapy. 2009 [PMID19517476; PMC3079554]

Authors
G Sonpavde;B Goldman;VO Speights;SP Lerner;DP Wood;SP Lerner;DL Trump;RB Natale;HB Grossman;ED Crawford
Journal / Conference
Cancer 115(18):4104-4109
Year
2009
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)

Cisplatin (Cis) + irinotecan (CPT11) vs. Cis + etoposide (VP16) in extensive stage small cell lung cancer (E-SCLC): final comparative outcomes analysis of JCOG 9511 and SWOG 0124

Authors
PN Lara;K Chansky;T Shibata;H Fukuda;T Tamura;N Saijo;HJ Lenz;RB Natale;JJ Crowley;DR Gandara
Journal / Conference
Journal of Clinical Oncology 27:15s, abst. #8027
Year
2009
Research Committee(s)
Lung
Study Number(s)
S0124

A phase II trial of imatinib mesylate in Merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331)

Authors
WE Samlowski;J Moon;RJ Tuthill;MC Heinrich;NS Balzer-Haas;SA Merl;RC DeConti;JA Thompson;LE Flaherty;VK Sondak
Journal / Conference
Journal of Clinical Oncology 27:15s, abst.#9056
Year
2009
Research Committee(s)
Melanoma
Study Number(s)
S0331

Expression of EGFR protein and markers of epithelial-mesenchymal transformation (DMT) in cetuximab/chemotherapy-treated non-small cell lung cancer (NSCLC)

Authors
WA Franklin;DR Gandara;ES Kim;RS Herbst;J Moon;M Redman;C Olsen;FR Hirsch;P Mack;K Kelly
Journal / Conference
Journal of Clinical Oncology 27:15s, abst. #11076
Year
2009
Research Committee(s)
Lung
Study Number(s)
S0342, S0536

SWOG 0354: a phase II trial of CNT0328, a monoclonal antibody against interleukin-6 (IL-6), in chemotherapy pre-treated patients (pts) with castration resistant prostate cancer (CRPC)

Authors
J Pinski;B Goldman;T Dorff;P Mack;PN Lara;PJ Van Veldhuizen;D Quinn;MHA Hussain;IM Thompson
Journal / Conference
Journal of Clinical Oncology 27:15s, abst.#5143
Year
2009
Research Committee(s)
Genitourinary
Study Number(s)
S0354

Oxaliplatin (OXP) plus protracted infusion 5-fluorouracil (PIFU) and external beam radiation (EBRT) prior to surgery (S) for potentially curable esophageal adenocarcinoma (EA): a Southwest Oncology Group (SWOG) phase II trial with molecular correlates (S0356)

Authors
L Leichman;B Goldman;C Thomas;K Billingsley;C Corless;HJ Lenz;S Iqbal;J Benedetti;P Gold;CD Blanke
Journal / Conference
Journal of Clinical Oncology 27:15s, abst.#4513
Year
2009
Research Committee(s)
Gastrointestinal
Study Number(s)
S0356

A phase II trial of sorafenib in patients with relapsing and resistant multiple myeloma (MM) previously treated with bortezomib (S0434)

Authors
G Srkalovic;M Hussein;V Bolejack;A Hoering;JA Zonder;B Barlogie
Journal / Conference
Journal of Clinical Oncology 27:15s, abst. #e19517
Year
2009
Research Committee(s)
Myeloma
Study Number(s)
S0434

SWOG S0509: A phase II study of novel oral anti-angiogenic agent AZD2171 (NSC-732208) in malignant pleural mesothelioma

Authors
LL Garland;M Redman;A Wozniak;AS Tsao;S Gadgeel;C Vershraegen;M Da Silva;K Chansky;DR Gandara
Journal / Conference
Journal of Clinical Oncology 27:15s, abst. #7511
Year
2009
Research Committee(s)
Lung
Study Number(s)
S0509

Phase I evaluation of lapatinib and everolimus in patients (pts) with advanced malignancies: Southwest Oncology Group trial (S0528)

Authors
CJ Hoban;A Hoering;TW Synold;V Chung;DR Gandara;AF Schott;L Kingsbury;D Lew;P LoRusso;SM Gadgeel
Journal / Conference
Journal of Clinical Oncology 27:15s, abst. 3553 (poster)
Year
2009
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S0528

Chemoradiation of resected gastric cancer: a 10 year followup of INT0116 (SWOG 9008)

Authors
J Macdonald;J Benedetti;SR Smalley;D Haller;S Hundahl;J Jessup;J Ajani;LL Gunderson;B Goldman;JA Martenson
Journal / Conference
Journal of Clinical Oncology 27:15s, abst. #4515
Year
2009
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)